<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Chu H</submitter><funding>NIAID NIH HHS</funding><pagination>2252</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC5440393</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>7(1)</volume><pubmed_abstract>Pulmonary fibrosis is a kind of devastating interstitial lung disease due to the limited therapeutic strategies. Traditional Chinese medicine (TCM) practices have put forth Shenks as a promising treatment approach. Here, we performed in vivo study and in vitro study to delineate the anti-fibrotic mechanisms behind Shenks treatment for pulmonary fibrosis. We found that regardless of the prophylactic or therapeutic treatment, Shenks was able to attenuate BLM-induced-fibrosis in mice, down regulate extracellular matrix genes expression, and reduce collagen production. The aberrantly high Smad3 phosphorylation levels and SBE activity in TGF-β-induced fibroblasts were dramatically decreased as a result of Shenks treatment. At the same time, Shenks was able to increase the expression of antioxid</pubmed_abstract><journal>Scientific reports</journal><pubmed_title>Treatment effects of the traditional Chinese medicine Shenks in bleomycin-induced lung fibrosis through regulation of TGF-beta/Smad3 signaling and oxidative stress.</pubmed_title><pmcid>PMC5440393</pmcid><funding_grant_id>U01 AI090909</funding_grant_id><pubmed_authors>Cui J</pubmed_authors><pubmed_authors>Liu Q</pubmed_authors><pubmed_authors>Ma Y</pubmed_authors><pubmed_authors>Jiang S</pubmed_authors><pubmed_authors>Zhou X</pubmed_authors><pubmed_authors>Wang J</pubmed_authors><pubmed_authors>Zhao Y</pubmed_authors><pubmed_authors>Shi X</pubmed_authors><pubmed_authors>Shi Y</pubmed_authors><pubmed_authors>Ding W</pubmed_authors><pubmed_authors>Zhong Q</pubmed_authors><pubmed_authors>Guo G</pubmed_authors><pubmed_authors>Chu H</pubmed_authors><pubmed_authors>Jin L</pubmed_authors></additional><is_claimable>false</is_claimable><name>Treatment effects of the traditional Chinese medicine Shenks in bleomycin-induced lung fibrosis through regulation of TGF-beta/Smad3 signaling and oxidative stress.</name><description>Pulmonary fibrosis is a kind of devastating interstitial lung disease due to the limited therapeutic strategies. Traditional Chinese medicine (TCM) practices have put forth Shenks as a promising treatment approach. Here, we performed in vivo study and in vitro study to delineate the anti-fibrotic mechanisms behind Shenks treatment for pulmonary fibrosis. We found that regardless of the prophylactic or therapeutic treatment, Shenks was able to attenuate BLM-induced-fibrosis in mice, down regulate extracellular matrix genes expression, and reduce collagen production. The aberrantly high Smad3 phosphorylation levels and SBE activity in TGF-β-induced fibroblasts were dramatically decreased as a result of Shenks treatment. At the same time, Shenks was able to increase the expression of antioxid</description><dates><release>2017-01-01T00:00:00Z</release><publication>2017 May</publication><modification>2025-04-26T11:05:50.831Z</modification><creation>2019-03-27T02:45:37Z</creation></dates><accession>S-EPMC5440393</accession><cross_references><pubmed>28533545</pubmed><doi>10.1038/s41598-017-02293-z</doi></cross_references></HashMap>